Book a free 15 Minute Discovery Call to understand how peptides might fit into your treatment plan to help restore balance from the inside out
Body measurements including waist, hips, thighs, and arms at consistent points provide direct feedback on composition changes
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a selective NNMT inhibitor that boosts NAD+ levels, enhancing mitochondrial function and fat oxidation
Weight loss is not just about appearanceits also about feeling good from the inside out
Thyroid medications deserve particular attention